This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

Please provide your email address to receive an email when new articles are posted on . Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out ...

Patients requiring intraoperative conversion from robotic-assisted radical cystectomy to open surgery have higher 90-day mortality rates and 30-day readmission rates. Intraoperative conversion from ...

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a median of 82 vs 80 days alive and out of the hospital within 90 days of surgery. While ...

A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...

Impact of neoadjuvant chemotherapy on 30-day radical cystectomy outcomes. SPADE: Design of a real-world observational study of avelumab first-line (1L) maintenance in advanced urothelial carcinoma (UC ...

Robot-assisted and open radical cystectomy are associated with similar 90-day complication rates, health-related quality of life, and clinical outcomes, according to a recent real-world study.

In the past decade there has been a rapid expansion of the use of robotic assistance during surgery that involves minimally invasive approaches. In the United Kingdom, robot-assisted radical ...

By: Janet Baack Kukreja, Mohamed A. Seif, Marissa W. Merry, James R. Incalcaterra, Ashish M. Kamat, Colin P. Dinney, Jay B. Shah, Thomas W. Feeley and Neema Navai ...